2001
DOI: 10.1006/jmbi.2001.4450
|View full text |Cite
|
Sign up to set email alerts
|

Structure and functionality of a designed p53 dimer11Edited by P. E. Wright

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

8
75
0
1

Year Published

2006
2006
2020
2020

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 68 publications
(85 citation statements)
references
References 58 publications
8
75
0
1
Order By: Relevance
“…It has been shown by several laboratories that dimers (and such a hetero-tetramer is a functional dimer) retains approximately 50% of the activity of the tetramer. 16,17 Using TAp73β containing the homo mutants, however, did not show a reduction in activity, proving that hetero-tetramer formation was suppressed (Supplementary Figure S7B).…”
Section: Inhibition Of the Transcriptional Activity Of Tap73β Bymentioning
confidence: 95%
“…It has been shown by several laboratories that dimers (and such a hetero-tetramer is a functional dimer) retains approximately 50% of the activity of the tetramer. 16,17 Using TAp73β containing the homo mutants, however, did not show a reduction in activity, proving that hetero-tetramer formation was suppressed (Supplementary Figure S7B).…”
Section: Inhibition Of the Transcriptional Activity Of Tap73β Bymentioning
confidence: 95%
“…[16][17][18] It is a structural domain that forms a tetramer, and mutations within the OD that inhibit tetramerization of p53 result in greatly reduced transcriptional activity. 19 In addition, several protein-protein interactions and posttranslational modifications require the tetrameric state as well, 16 and mutations in the OD of p53 that prevent oligomerization have been identified in human cancers. 20,21 Owing to its functional importance, the OD of p53 has been the target of several structure determination projects.…”
mentioning
confidence: 99%
“…To probe the role that oligomerization plays in p53 binding to Cul7-CPH, we performed NMR titrations using two previously designed and characterized p53 mutants, M340Q/L344R (MQLR) and L344P, which are dimeric and monomeric forms of the p53 protein, respectively (36). As shown in Fig.…”
mentioning
confidence: 99%